Molecular biomarkers and histological parameters impact on survival and response to first- line systemic therapy of metastatic colorectal cancer patients

Categoría del artículo: Research Article

Publicado en línea: 03 mar 2019

Páginas: 85 - 95

Recibido: 30 ago 2018

Aceptado: 20 sept 2018

DOI: https://doi.org/10.2478/raon-2019-0013

Palabras clave

metastatic colorectal cancer, chemotherapy, targeted therapy, histological parameters, biomarkers

© 2019 Martina Rebersek, Tanja Mesti, Marko Boc, Janja Ocvirk, published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.